⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.
Precision Geromedicine Protocols
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-11 — Longevitomics as the Science of the Longevitome: Towards a Unified Systems Science of Healthy Longevity.: Conceptual review [expert-opinion] positions ‘Longevitomics’ as an integrated systems framework for modeling individual healthy-longevity trajectories, extending the rationale for precision geromedicine without new primary data validating prediction-guided protocols, intervention safety, or improved healthspan; commercial adoption and media spread are not established by this finding. [expert-opinion] (novelty: 3)
- 2026-11-10 — Reframing disease elimination: an update from the Lancet Commission on chronic obstructive pulmonary disease.: Lancet Commission review/update [expert-opinion] advocates precision-based preservation of lifelong lung health rather than reactive late-stage COPD management, extending the institutional discourse around proactive personalized prevention without establishing efficacy or safety of commercial precision-geromedicine protocols. [expert-opinion] (novelty: 3)
- 2026-10-20 — From Benefit to Harm: Context-Dependent Responses to Dietary Interventions.: Review synthesis [expert-opinion], with no new primary data, describes context-dependent neurodegeneration and tumor-metastasis signals under calorie restriction, fasting, or ketogenic diets in relation to mitochondrial integrity, immune state, tissue context, and oncogenic alterations; these safety concerns motivate questions about personalization but do not establish human risk estimates or validate screening-guided dietary protocols. [expert-opinion] (novelty: 3)
- 2026-10-01 — Precision Microbiota Interventions for Senoreduction Trial: Randomized crossover trial of GRAS microbiota interventions targeting immune-senescence biomarkers in HIV + alcohol users extends the precision-geromedicine framing into a stratified-population senotherapeutic probe using microbiota rather than drugs, protocol only, no efficacy data. [expert-opinion] (novelty: 3)
- 2026-10-02 — FDA Leaders Name Longevity a Priority at ARDD: 2026 — FDA officials at ARDD signaled aging will enter the agency’s regulatory science agenda, a mainstreaming signal for the eventual regulatory path of gerotype-stratified and multi-modal protocols like PROMETHEUS; news coverage of agency statements, no guidance text. [expert-opinion] (novelty: 4)
- 2026-10-01 — Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.: 2026 — Conceptual review reframes endothelial TLR4 as a context- and cell-type-specific driver of vascular senescence and argues for spatiotemporally targeted senotherapeutics (VCAM-1/E-selectin-tagged nanoparticles, engineered plant exosomes) after systemic pan-TLR4 blockade failures; extends the precision-targeting/delivery axis of precision geromedicine, review synthesis only, no new primary data. [expert-opinion] (novelty: 3)
- 2026-07-06 — From organ age gaps to precision geromedicine: Multi-omic and imaging frameworks for heterogeneous biological aging.: 2026 — Conceptual review introduces an ORGAN-AGE framework proposing multi-omic/imaging/digital-derived organ age gaps as targets for organ-level precision geromedicine, while cautioning that circulating signals rarely prove tissue origin and cross-organ coupling should be read as graded inference pending longitudinal/experimental validation; framing synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-08-18 — The nutrition-sleep-circadian axis in age-related neurodegeneration: Cellular mechanisms, metabolic dysfunction, and neuroprotective interventions.: 2026 — Integrative review reframes nutrition, sleep, and circadian biology as a single axis driving AD/PD risk and maps multi-target lifestyle levers (chrononutrition, Mediterranean diet, time-restricted feeding, circadian light) as candidate stacks for brain-aging protocols; mechanism synthesis only, no new primary trial data. [expert-opinion] (novelty: 3)
- 2026-10-01 — uPAR-Targeting T Cell Engager Exerts Senolytic Effects in Mice and Non-Human Primates With Serum Aminotransferase Activity as a Safety Monitor.: cross-connection with bispecific-tce-senolytics: Dose-titratable biologic senolytics with a biomarker-gated dosing scheme fit the precision-geromedicine framing of monitored, titrated senotherapeutics. (novelty: 4)
- 2026-10-01 — Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.: Review frames TCM multi-herb formulas as a multi-pathway complement to precision geromedicine, with AI/network pharmacology and proteomic aging clocks proposed as the stratification/readout layer; synthesis only, no new trial data. [expert-opinion] (novelty: 3)
- 2026-09-15 — WHO-ICOPE-Aligned Multidomain Interventions for Intrinsic Capacity in Community-Dwelling Older Adults: A Systematic Review of Randomised Controlled Trials.: Systematic review of 5 RCTs on WHO-ICOPE-aligned multidomain care extends the personalization-by-domain-deficit axis of precision geromedicine into a community-dwelling older-adult framework, with locomotion/vitality signals but limited and heterogeneous evidence overall. [human-rct] (novelty: 3)
- 2026-09-10 — EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.: 2026 — Pilot single-arm trial (1 mg/day rapamycin × 4 weeks) reported >15% cerebral blood flow increases and improved metabolic/inflammatory profiles selectively in middle-aged APOE4 carriers vs minimal effect in non-carriers; extends the genotype-stratified personalization axis into cerebrovascular endpoints, uncontrolled pilot, no comparator. [human-observational] (novelty: 3)
- 2026-08-25 — Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy: 2026 — Feasibility trial will test whether embedding a brief Practical Geriatric Assessment into SBRT workflow for older NSCLC patients raises supportive-care referrals, with FaceAge AI as a secondary vulnerability flag; extends precision-geromedicine framing into oncology care-pathway personalization, implementation-feasibility design, no efficacy data. [expert-opinion] (novelty: 3)
- 2026-08-27 — A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation: 2026 — Feasibility trial protocol combining supervised exercise + spermidine + either rapamycin or lamivudine, with systemic inflammation as the readout; extends the multi-modal stacking axis of precision geromedicine into pharmacologic combinations, design/feasibility only, no efficacy data. [expert-opinion] (novelty: 3)
- 2026-08-28 — Michael Snyder: We Need to Track Health, Not Disease: 2026 — Michael Snyder media interview restates his continuous wearable + multi-omic health-tracking thesis (track health trajectories, not disease); credentialed-expert commentary reinforcing the precision/proactive-monitoring framing, no new trial or biomarker-validation data. [expert-opinion] (novelty: 3)
- 2026-09-08 — 100-Year Human Aging Study: 2026 — 100-Year Human Aging Study announced as a purpose-built longitudinal cohort to test which single or combined multi-system markers actually predict mortality and disability endpoints — directly targets the surrogate-endpoint validation gap that precision geromedicine protocols currently rely on; cohort design only, no readouts. [expert-opinion] (novelty: 4)
- 2026-08-27 — CatchU: A Quantitative Multisensory Falls-Assessment Study: 2026 — CatchU iPhone app quantifying visual-somatosensory integration for falls-risk stratification reported in a 300-patient pilot with acceptable-to-excellent predictive accuracy; extends the precision-assessment axis into mobile multisensory phenotyping, pilot-stage validation only. [human-observational] (novelty: 3) [human-observational] (novelty: 3)
- 2026-07-13 — #399 ‒ The evolution of Alzheimer’s disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.: 2026 — Peter Attia podcast #399 with neurologist Gayatri Devi framing early Alzheimer’s diagnosis plus personalized/multimodal dementia care (new anti-amyloid agents, lifestyle stacking, cognitive-reserve building) as a shifting standard of practice; extends the precision-personalization framing to AD care but is clinician media commentary, no new trial data. [expert-opinion] (novelty: 3)
- 2026-03-17 — Gut Microbiota Resilience and Environmental Stressors: A Hidden Key to Lifespan Optimization?: Narrative review argues precision multi-omics profiling of gut microbiota resilience should feed into personalized longevity protocols — extends the precision-geromedicine framing to a microbiome axis, no new trial data. [expert-opinion] (novelty: 3)
- 2026-06-10 — Artificial intelligence across the aging continuum: Mechanistic geroscience, therapeutic innovation, and clinical impact.: Review frames AI-enabled personalization (multi-omic gerotype stratification, adaptive geriatric care) as a scaffold for precision geromedicine, conditional on validation rigor and equity safeguards; no new trial data. [expert-opinion] (novelty: 3)
- 2026-06-12 — Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases.: 2026-07 — Review of CAR T cells as living senolytics extends the senotherapeutics axis of precision geromedicine with a cell-therapy modality; synthesis of preclinical target-discovery and mouse fibrosis/metabolic data, no human efficacy readouts. [animal-model] (novelty: 3)
- 2026-06-28 — From lifespan extension to hallmark-informed gerotherapeutic prioritization: A bibliometric-guided, strategy-oriented review of anti-aging drug research.: Bibliometric-guided review (2005–2025) proposes a three-axis map of anti-aging drug research (senotherapeutics, nutrient-sensing/metabolic gerotherapeutics, homeostasis-restoring agents) as a candidate-prioritization framework for precision geromedicine; synthesis only, no new primary data. [expert-opinion] (novelty: 3)
- 2026-07-03 — PROMETHEUS clinical trial protocol: tailoring healthy ageing with lifestyle and nutraceuticals.: PROMETHEUS protocol paper published: 8-week, n=20 feasibility trial (XPRIZE Healthspan semi-finalist) stacking sleep/diet coaching, whey, creatine, fucoidan, supervised dual-task exercise plus gerotype-tailored urolithin A / NMN / multivitamin (± ergothioneine); design only, no efficacy readout. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review).
13-nov-2026
novelty 2
per-area 2
introduces
Chronobiology of Aging: Interactions Between Circadian Rhythms, Oxidative Stress, and Inflammation.
12-nov-2026
novelty 3
per-area 2
mentions
Longevitomics as the Science of the Longevitome: Towards a Unified Systems Science of Healthy Longevity.
11-nov-2026
novelty 3
per-area 3
strengthens
Reframing disease elimination: an update from the Lancet Commission on chronic obstructive pulmonary disease.
10-nov-2026
novelty 3
per-area 3
strengthens
500 people, six months, one goal: Reverse aging
10-nov-2026
novelty 2
per-area 2
mentions
Inflammaging as a Dynamic Process in Ageing: Context, Regulation and Functional Consequences.
01-nov-2026
novelty 3
per-area 2
mentions
Head and neck cancer in older adults: biological aging, treatment tolerance, and survivorship.
26-oct-2026
novelty 2
per-area 2
strengthens
From Benefit to Harm: Context-Dependent Responses to Dietary Interventions.
20-oct-2026
novelty 3
per-area 3
strengthens
Screening for Geriatric Problems in Older Adults Receiving Hemodialysis Using a Self-Administered Battery.
10-oct-2026
novelty 2
per-area 2
strengthens
Taining Golden Lake Comprehensive Chronic Disease Management Initiative
06-oct-2026
novelty 2
per-area 2
introduces
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
06-oct-2026
novelty 2
per-area 2
strengthens
Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention
02-oct-2026
novelty 2
per-area 2
mentions
FDA Leaders Name Longevity a Priority at ARDD
02-oct-2026
novelty 4
per-area 4
strengthens
Mapping the evolution of dual-task paradigms in cognitive aging: A bibliometric analysis of research landscapes and translational applications.
02-oct-2026
novelty 2
per-area 2
mentions
Precision Microbiota Interventions for Senoreduction Trial
01-oct-2026
novelty 3
per-area 3
strengthens
Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.
01-oct-2026
novelty 3
per-area 3
strengthens
Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.
01-oct-2026
novelty 3
per-area 3
strengthens
The end of Alzheimer’s?
30-sep-2026
novelty 2
per-area 2
mentions
Prioritizing health interventions
26-sep-2026
novelty 2
per-area 2
mentions
Biological aging for the advancement of biogerontology: Between hopes and hypes.
26-sep-2026
novelty 2
per-area 2
strengthens
Healthy Ageing without Health Equity? Capability, Justice, and Ageing Governance in the UN Decade.
24-sep-2026
novelty 2
per-area 2
mentions
PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study
22-sep-2026
novelty 2
per-area 2
strengthens
Multidomain Intervention Based on ICOPE
18-sep-2026
novelty 2
per-area 2
mentions
Social cognitive training may offer the most promising digital health approach to reduce loneliness among older adults.
17-sep-2026
novelty 2
per-area 2
mentions
WHO-ICOPE-Aligned Multidomain Interventions for Intrinsic Capacity in Community-Dwelling Older Adults: A Systematic Review of Randomised Controlled Trials.
15-sep-2026
novelty 3
per-area 3
strengthens
#407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and promising new therapies | Michael Davidson, M.D.
14-sep-2026
novelty 3
per-area 2
mentions
Bone aging: a paradigm of multiscale degeneration and targeted rejuvenation.
14-sep-2026
novelty 2
per-area 2
mentions
Aging is Complex, So Expect High Variance in the Details Between Individuals
11-sep-2026
novelty 2
per-area 2
mentions
Digital Healthy Aging in China: Current Landscape and the Way Forward.
11-sep-2026
novelty 2
per-area 2
mentions
Resilience and Equity in Aging, Cancer, and Health (REACH)
10-sep-2026
novelty 2
per-area 2
strengthens
EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.
10-sep-2026
novelty 3
per-area 3
strengthens
Perioperative Prehabilitation on Markers of Fitness and Frailty in Patients Undergoing Elective Surgery
10-sep-2026
novelty 2
per-area 2
mentions
100-Year Human Aging Study
08-sep-2026
novelty 4
per-area 4
strengthens
Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment
07-sep-2026
novelty 3
per-area 2
mentions
Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
02-sep-2026
novelty 2
per-area 2
mentions
Rejuvenation Roundup August 2026
01-sep-2026
novelty 1
per-area 2
mentions
Management and Outcomes of Patients Admitted to Coronary Care Units, Depending on Degree of Frailty and Comorbidities
31-aug-2026
novelty 2
per-area 2
mentions
Michael Snyder: We Need to Track Health, Not Disease
28-aug-2026
novelty 3
per-area 3
strengthens
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
27-aug-2026
novelty 3
per-area 3
strengthens
CatchU: A Quantitative Multisensory Falls-Assessment Study
27-aug-2026
novelty 3
per-area 3
strengthens
Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
25-aug-2026
novelty 3
per-area 3
strengthens
Efficacy of a Multidomain Intervention on Lifestyle Risk Factors for Dementia Prevention
25-aug-2026
novelty 2
per-area 2
introduces
#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease
24-aug-2026
novelty 2
per-area 2
mentions
How a physician with a 1 a.m. bedtime optimizes his health: I try to 'tick all the longevity boxes that I can'
22-aug-2026
novelty 2
per-area 2
mentions
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
19-aug-2026
novelty 2
per-area 2
mentions
The nutrition-sleep-circadian axis in age-related neurodegeneration: Cellular mechanisms, metabolic dysfunction, and neuroprotective interventions.
18-aug-2026
novelty 3
per-area 3
strengthens
Clinical applications of point-of-care ultrasound for infectious diseases in older adults.
13-aug-2026
novelty 2
per-area 3
introduces
Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried
13-aug-2026
novelty 3
per-area 2
mentions
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study
10-aug-2026
novelty 3
per-area 2
mentions